Produktname:3-[4-({[(2-bromophenyl)methyl]carbamoyl}methyl)-3-oxo-3,4-dihydroquinoxalin-2-yl]-N-(2-methylpropyl)propanamide

IUPAC Name:3-[4-({[(2-bromophenyl)methyl]carbamoyl}methyl)-3-oxo-3,4-dihydroquinoxalin-2-yl]-N-(2-methylpropyl)propanamide

CAS:1251615-34-5
Molekulare Formel:C24H27BrN4O3
Reinheit:95%+
Katalognummer:CM856062
Molekulargewicht:499.41

Packungseinheit Verfügbarer Vorrat Preis($) Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1251615-34-5
Molekulare Formel:C24H27BrN4O3
Schmelzpunkt:-
SMILES-Code:CC(C)CNC(=O)CCC1=NC2=C(C=CC=C2)N(CC(=O)NCC2=C(Br)C=CC=C2)C1=O
Dichte:
Katalognummer:CM856062
Molekulargewicht:499.41
Siedepunkt:
Mdl-Nr.:
Lagerung:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.